Capromorelin Tartrate

CAS No. 193273-69-7

Capromorelin Tartrate( CP 424391-18 )

Catalog No. M23880 CAS No. 193273-69-7

Capromorelin Tartrate is a potent, orally active growth hormone secretagogue receptor (GHSR) agonist (Ki: 7 nM for hGHS-R1a).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 31 In Stock
10MG 55 In Stock
25MG 122 In Stock
50MG 210 In Stock
100MG 312 In Stock
200MG 445 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Capromorelin Tartrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Capromorelin Tartrate is a potent, orally active growth hormone secretagogue receptor (GHSR) agonist (Ki: 7 nM for hGHS-R1a).
  • Description
    Capromorelin Tartrate is a potent, orally active growth hormone secretagogue receptor (GHSR) agonist (Ki: 7 nM for hGHS-R1a).(In Vitro):Capromorelin stimulates GH release in rat pituitary cell cultures with EC50 of 3 nM.(In Vivo):Dogs receiving capromorelin (30 mg/mL) have food consumption that is significantly greater than dogs treated with placebo. All dogs in the capromorelin group gain weight by 0.52 kg, more than that of placebo group. Capromorelin shows enhanced intestinal absorption in rodent models and exhibits superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%]. Capromorelin stimulates GH release in anesthesized rat model, with ED50 of 0.05 mg/kg iv.
  • In Vitro
    Capromorelin stimulates GH release in rat pituitary cell cultures with EC50 of 3 nM.
  • In Vivo
    Dogs receiving capromorelin (30 mg/mL) have food consumption that is significantly greater than dogs treated with placebo. All dogs in the capromorelin group gain weight by 0.52 kg, more than that of placebo group. Capromorelin shows enhanced intestinal absorption in rodent models and exhibits superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%]. Capromorelin stimulates GH release in anesthesized rat model, with ED50 of 0.05 mg/kg iv.
  • Synonyms
    CP 424391-18
  • Pathway
    GPCR/G Protein
  • Target
    GHSR
  • Recptor
    hGHS-R1a
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    193273-69-7
  • Formula Weight
    655.7
  • Molecular Formula
    C32H40N5O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (152.51 mM)
  • SMILES
    O=C([C@@H]([C@@H](O)C(O)=O)O)O.CC(C)(N)C(N[C@H](COCC1=CC=CC=C1)C(N(C[C@]23CC4=CC=CC=C4)CCC2=NN(C)C3=O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Carpino PA, et al. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorg Med Chem. 2003 Feb 20;11(4):581-90.
molnova catalog
related products
  • Anamorelin fumarate

    A non-peptide, centrally-penetrant and selective agonist of GHSR with appetite-enhancing and anabolic effects.

  • Human growth hormone...

    Human growth hormone-releasing factor stimulates GH production and release by binding to the GHRH Receptor (GHRHR) on cells in the anterior pituitary.Growth hormone-releasing hormone is a hormone produced in the hypothalamus. The main role of growth hormone-releasing hormone is to stimulate the pituitary gland to produce and release growth hormone into the bloodstream.

  • TAPI-1

    TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.